Clinical Trials Logo

Clinical Trial Summary

CLET is a published treatment for the management of corneal failure due to extensive LSCD. Due to our previous studies on this novel treatment, the regulatory agency of Spain "Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)" authorized our institution (IOBA-University of Valladolid) to perform this kind of therapy (CLET) in a case-by-case base following the Special Situation Medicines Policy Procedure in Spain. Upon approval of the permanent authorization patients will be included as specified by AEMPS.The objective of this study is to perform a protocolized treatment and follow up so that results can be reported to the scientific community.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03884569
Study type Observational
Source Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
Contact Margarita Calonge, MD, PhD
Phone 34983184750
Email calonge@ioba.med.uva.es
Status Not yet recruiting
Phase
Start date April 1, 2022
Completion date December 31, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT03957954 - Stem Cell Therapy for Limbal Stem Cell Deficiency Phase 1
Recruiting NCT05909735 - Treatment of LSCD With DM Phase 1
Completed NCT03594370 - Multiple Noninvasive Examination Modality to Evaluate the Severity of Ocular Surface Disorders
Recruiting NCT04021875 - The Effects of Autologous SLET
Recruiting NCT04021134 - The Effects of Allogeneic SLET
Completed NCT03226015 - Autologous Oral Mucosa Transplantation for Limbal Stem Cell Deficiency N/A
Recruiting NCT04995926 - Labial Mucosal Epithelium Grafting for Corneal Limbus Substitution N/A
Completed NCT05461469 - CDL Validation Study
Completed NCT02415218 - Transplantation of Autologous Oral Mucosal Epithelial Sheets for Limbal Stem-cell Deficiency Phase 1/Phase 2